Gene copy number, gene configuration and LC / HC mRNA ratio impact on antibody productivity and product quality in targeted integration CHO cell lines
Biotechnology Progress · 2024
DOI: 10.1002/btpr.3433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, 2024. Verfasst von Zion Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Culture and Bioprocess Operations, Genentech, Inc., San Francisco, California, USA. Hauptthemen laut MEDLINE: Cricetulus, RNA, Messenger, Gene Dosage. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Genentech.
Abstract (Originalsprache)
The augmentation of transgene copy numbers is a prevalent approach presumed to enhance transcriptional activity and product yield. CHO cell lines engineered via targeted integration (TI) offer an advantageous platform for investigating the interplay between gene copy number, mRNA abundance, product yield, and product quality. Our investigation revealed that incrementally elevating the gene copy numbers of both IgG heavy chain (HC) and light chain (LC) concurrently resulted in the attainment of plateaus in mRNA levels and product titers, notably occurring beyond four to five gene copies integrated at the same TI site. Furthermore, maintaining a fixed gene copy number while varying the position of genes within the vector influenced the LC/HC mRNA ratio, which subsequently exerted a substantial impact on product titer. Moreover, manipulation of the LC/HC gene ratio through the introduction of surplus LC gene copies led to heightened LC mRNA expression and a reduction in the levels of high molecular weight species. It is noteworthy that the effects of excess LC on product titer were dependent on the specific molecule under consideration. The strategic utilization of PCR tags enabled precise quantification of transcription from each expression slot within the vector, facilitating the identification of highly expressive and less expressive slots. Collectively, these findings significantly enhance our understanding of stable antibody production in TI CHO cell lines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Culture and Bioprocess Operations, Genentech, Inc., San Francisco, California, USA.
ORCID-Profile: Zion Lee, Jun Wan, Gavin Barnard
Förderung
- Genentech
Zitieren
APA
Lee, Z., Wan, J., Shen, A., & Barnard, G. (2024). Gene copy number, gene configuration and LC / HC mRNA ratio impact on antibody productivity and product quality in targeted integration CHO cell lines. Biotechnology Progress. https://doi.org/10.1002/btpr.3433
Vancouver
Lee Z, Wan J, Shen A, Barnard G. Gene copy number, gene configuration and LC / HC mRNA ratio impact on antibody productivity and product quality in targeted integration CHO cell lines. Biotechnology Progress. 2024. doi:10.1002/btpr.3433
BibTeX
@article{Lee2024,
author = {Lee, Zion and Wan, Jun and Shen, Amy and Barnard, Gavin},
title = {Gene copy number, gene configuration and LC / HC mRNA ratio impact on antibody productivity and product quality in targeted integration CHO cell lines},
journal = {Biotechnology Progress},
year = {2024},
doi = {10.1002/btpr.3433}
}
EUVIMED